Chemoinformaics analysis of cis-3-Hexenyl salicylate
| Molecular Weight | 220.268 | nRot | 5 |
| Heavy Atom Molecular Weight | 204.14 | nRig | 8 |
| Exact Molecular Weight | 220.11 | nRing | 1 |
| Solubility: LogS | -3.514 | nHRing | 0 |
| Solubility: LogP | 3.394 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 34.7847 |
| nHD | 1 | BPOL | 18.6553 |
| QED | 0.471 |
| Synth | 2.104 |
| Natural Product Likeliness | 0.738 |
| NR-PPAR-gamma | 0.448 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.045 |
| HIA | 0.015 |
| CACO-2 | -4.642 |
| MDCK | 0.0000273 |
| BBB | 0.357 |
| PPB | 0.961463 |
| VDSS | 0.576 |
| FU | 0.0287534 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.816 |
| CYP2c19-inh | 0.931 |
| CYP2c19-sub | 0.214 |
| CYP2c9-inh | 0.621 |
| CYP2c9-sub | 0.855 |
| CYP2d6-inh | 0.853 |
| CYP2d6-sub | 0.873 |
| CYP3a4-inh | 0.461 |
| CYP3a4-sub | 0.175 |
| CL | 11.023 |
| T12 | 0.927 |
| hERG | 0.079 |
| Ames | 0.062 |
| ROA | 0.025 |
| SkinSen | 0.904 |
| Carcinogencity | 0.372 |
| EI | 0.974 |
| Respiratory | 0.128 |
| NR-Aromatase | 0.142 |
| Antiviral | Yes |
| Prediction | 0.568926 |